首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1542882

全球一次性醫院用品市場 - 2024-2031

Global Disposable Hospital Supplies Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

全球一次性醫療用品市場在 2023 年達到 4,784 億美元，預計到 2031 年將達到 9,673 億美元，2024-2031 年預測期間複合年成長率為 9.2%。

一次性醫院用品是用於臨時用於患者護理的一次性醫療產品，在初次使用後將被丟棄。這些物品對於維持衛生標準、預防感染以及保障醫院環境內病患和醫護人員的福祉至關重要。

一次性醫院用品包括各種醫療用品，包括但不限於注射器、針頭、手套、面罩、繃帶、導管、輸液器以及用於提供患者護理的多種其他消耗品。這些耗材涵蓋廣泛的應用，對於維持安全衛生的醫療環境至關重要。

一次性用品的主要目標是透過阻止病原體在患者和醫療保健提供者之間傳播來減少交叉污染和醫療保健相關感染 (HAI) 的可能性。這些用品旨在透過最大限度地降低感染傳播的風險來確保更安全的環境。

市場動態：

司機

外科手術數量不斷增加

全球一次性醫院用品市場的需求受到多種因素的推動。全球手術數量的增加是推動一次性醫院用品市場擴張的關鍵因素。隨著外科手術量的增加，一系列一次性物品的需求也隨之增加，例如手術服、手套、手術單、餵食管以及治療套件和托盤。

隨著外科手術數量的增加，人們越來越重視感染預防。一次性用品在降低交叉污染和院內感染 (HAI) 風險方面發揮著至關重要的作用，這些風險是手術環境中的重大問題。使用一次性物品可確保為每位患者提供無菌設備，從而提高患者安全。

此外，意識計劃、研究、合作和產品發布等政府措施將推動該市場的成長。例如，2024年1月，印度藥品監管局局長啟動了國家單一窗口系統（NSWS），以簡化醫療器材的監管流程。該舉措旨在創建一個綜合平台，作為“真正的單一窗口系統”，使投資者能夠在一個地方有效地管理所有必要的批准。

此外，2023 年 2 月，《柳葉刀》最近發表的評論強調了對醫療保健行業嚴重依賴一次性材料的嚴重擔憂。這種依賴往往是出於恐懼和對效率的感知需求，而不是強力的證據支持一次性用品優於徹底消毒的可重複使用的選擇。

同樣，2024 年 5 月，化學和肥料部製藥部門與印度工業聯合會 (CII) 合作發起了 MEDITECH STACKATHON。這項開創性的舉措旨在透過對選定的醫療設備進行全面的價值鏈分析，促進印度蓬勃發展的醫療科技產業的變革。

Stackathon將重點放在癌症治療、影像、重症監護、輔助醫療器材、身體植入、手術器械、醫院設備、消耗品和一次性用品以及IVD儀器和試劑等八個特定組別。

限制

一次性產品產生的廢物增加、一次性醫療用品報銷不足、嚴格的監管框架以及環境問題等因素預計將阻礙市場的發展。

細分市場分析

全球一次性醫院用品市場根據產品類型、應用、最終用戶和地區進行細分。

診斷供應商細分市場約佔全球一次性醫院用品市場佔有率的52.3%

預計診斷供應商細分市場將在預測期內佔據最大的市場佔有率。診斷用品包括在醫療保健環境中執行診斷測試和監測的各種必需物品。這些用品對於準確評估患者健康狀況和告知治療選擇至關重要。

診斷供應商包括測試套件、診斷成像供應商、試劑、醫療設備等。測試套件是預先組裝的套件，包含執行特定診斷測試所需的所有組件。它們可用於多種目的，包括血液檢測、尿液檢測和傳染病檢測。這些套件透過提供標準化材料和清晰的說明來簡化診斷過程。

此外，行業投資以及產品發布和批准的主要參與者將推動該市場的成長。例如，2024 年 8 月，專注於永續發展和包容性的現代個人防護裝備 (PPE) 品牌 AmorSui 宣布已成功籌集 350 萬美元種子資金。這筆資金旨在支持該公司的使命，創造不僅有效、而且環保且價格實惠的個人防護裝備。醫療用品行業嚴重依賴一次性產品，並且越來越面臨尋求永續替代品的壓力。

此外，2024 年 1 月，Inspira Technologies 宣布打算為其 INSPIRA ART 醫療設備系列推出一次性血液氧合套件，目前該套件正在開發中。該套件旨在與各種生命維持機器相容，使該公司能夠進入一次性灌注系統市場。推出該套件是 Inspira 更廣泛願景的一部分，即用先進的生命維持技術取代傳統的機械呼吸器。

同樣，2023 年 9 月，美敦力 (Medtronic plc) 宣布其新型一體式一次性 Simplera 連續血糖監測儀 (CGM) 已獲得 CE 標誌批准。這種創新設備具有簡單的兩步驟插入過程，不需要過度膠帶，使其方便用戶使用。 Simplera CGM 旨在與 InPen 智慧胰島素筆無縫協作，提供即時、個人化的劑量指導，以簡化糖尿病管理。

市場地域佔有率

北美約佔全球一次性醫院用品市場佔有率的44.7%

由於呼吸道合胞病毒（RSV）等傳染病發病率不斷上升，北美地區預計將在預測期內佔據最大的市場佔有率，這是推動北美一次性醫院用品需求的關鍵因素。 RSV 病例的增加，特別是在加拿大，導致對用於管理和預防這些感染的一次性產品的需求增加。

北美醫療保健支出的激增直接影響一次性醫院用品的供應和可用性。隨著該地區醫院投資擴大服務和升級設施，一次性用品的採購量也隨之增加，這些用品對於提供優質的病患照護和維持嚴格的感染控制方案至關重要。對醫療基礎設施的投資增加是推動北美一次性醫院用品市場成長的重要因素。

此外，大量關鍵參與者的存在、夥伴關係和協作等策略有助於推動該地區的市場成長。例如，2023 年 5 月，在美國，Indegene 宣布擴大與 ConTIPI Medical Ltd 的合作關係，ConTIPI Medical Ltd 是為患有各種骨盆底功能障礙的女性提供非手術和一次性解決方案的創新者。此次合作旨在向市場推出一種新設備，加強對患有骨盆器官脫垂 (POP) 的女性的支持。

同樣，2021 年 2 月，美國醫療用品和個人防護用品供應商 Health Professional Resources (HPR) 宣布與南亞最大的服裝和紡織品製造商 MAS Holdings 建立製造合作夥伴關係。此次合作將使HPR 能夠為醫療保健行業推出一系列新的高性能PPE 產品，所有產品均由MAS Holdings 製造，該公司在16 個國家擁有53 個製造基地，是Nike 和Victoria's Secret 等全球領先品牌的長期策略夥伴。 HPR 系列將包括手術服、隔離服、醫用手術服、可重複使用的口罩和其他個人防護裝備。

此外，先進的醫療保健基礎設施、關鍵參與者協議和產品批准有助於推動該市場的成長。例如，2022 年7 月，專門從事綜合呼吸護理的美國家庭醫療設備領域領先公司Quipt Home Medical Corpa 宣布與Cardinal Health, Inc.（紐約證券交易所股票代碼：）旗下子公司Cardinal Health at-Home 簽署契約。根據該協議，Quipt 將銷售一次性醫療用品，而 Cardinal Health 將在全國範圍內供應和分銷這些產品。

此外，2024年1月，法國諾和諾德旗下專門從事創新醫療器材設計和製造的子公司BIOCORP宣布已獲得美國食品藥物管理局（FDA）的510(k)上市許可獨奏智慧。這款智慧醫療設備旨在與賽諾菲生產的 SoloStar 胰島素筆連接。

Disposable hospital supplies are single-use medical products intended for temporary use in patient care, which are discarded after their initial application. These items are crucial for upholding hygiene standards, preventing infections, and safeguarding the well-being of both patients and healthcare workers within hospital environments.

Disposable hospital supplies encompass a diverse array of medical items, including but not limited to syringes, needles, gloves, face masks, bandages, catheters, infusion sets, and a multitude of other consumables utilized in the provision of patient care. These supplies cover a broad spectrum of applications and are essential for maintaining a safe and hygienic healthcare environment.

The main objective of disposable supplies is to reduce the likelihood of cross-contamination and healthcare-associated infections (HAIs) by stopping the spread of pathogens between patients and healthcare providers. These supplies are designed to ensure a safer environment by minimizing the risk of infection transmission.

Market Dynamics: Drivers

Rising number of surgical procedures

The demand for the global disposable hospital supplies market is driven by multiple factors. The growing number of surgeries conducted globally is a key factor propelling the expansion of the disposable hospital supplies market. As the volume of surgical procedures increases, so does the need for a range of disposable items such as surgical gowns, gloves, drapes, feeding tubes, and treatment sets and trays.

As the number of surgical procedures increases, there is an increased emphasis on infection prevention. Disposable supplies play a crucial role in reducing the risk of cross-contamination and hospital-acquired infections (HAIs), which are significant issues in surgical environments. Utilizing single-use items guarantees that every patient is provided with sterile equipment, thereby improving patient safety.

Moreover, government initiatives such as awareness programs, research studies, collaborations, and product launches would drive this market growth. For instance, in January 2024, the National Single Window System (NSWS) was launched by the Drugs Controller General of India to simplify the regulatory process for medical devices. This initiative aims to create a comprehensive platform that serves as a "genuine single-window system," allowing investors to efficiently manage all necessary approvals in one place.

Also, in February 2023, the recent commentary published in The Lancet highlights significant concerns regarding the healthcare industry's heavy reliance on disposable materials. This reliance is often driven by fear and a perceived need for efficiency, rather than robust evidence supporting the superiority of disposable supplies over thoroughly sterilized reusable options.

Similarly, in May 2024, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, launched the MEDITECH STACKATHON in collaboration with the Confederation of India Industry (CII). This groundbreaking initiative aims to catalyze transformative change within India's burgeoning MedTech sector by undertaking a comprehensive value chain analysis of select medical devices.

The stackathon will focus on eight specific groups cancer therapy, imaging, critical care, assistive medical devices, body implants, surgical instruments, and hospital equipment, consumables & disposables, and IVD instruments and reagents.

Restraints

Factors such as the rise in waste generated by disposable products, insufficient reimbursement for disposable medical supplies, stringent regulatory framework, and environmental concerns, are expected to hamper the market.

Market Segment Analysis

The global disposable hospital supplies market is segmented based on product type, application, end-user, and region.

The diagnostic suppliers segment accounted for approximately 52.3% of the global disposable hospital supplies market share

The diagnostic suppliers segment is expected to hold the largest market share over the forecast period. Diagnostic supplies include various essential items for performing diagnostic tests and monitoring in healthcare environments. These supplies are vital for accurately evaluating patient health and informing treatment choices.

Diagnostic suppliers include test kits, diagnostic imaging suppliers, reagents, medical devices, and many others. Test kits are pre-assembled sets that contain all the required components for carrying out specific diagnostic tests. They can be utilized for a variety of purposes, including blood tests, urine tests, and infectious disease detection. These kits streamline the diagnostic process by providing standardized materials and clear instructions.

Moreover, key players in the industry investments and product launches & approvals that would drive this market growth. For instance, in August 2024, AmorSui, a modern personal protective equipment (PPE) brand focused on sustainability and inclusivity, announced that it had successfully raised $3.5 million in seed funding. This funding aims to support the company's mission to create PPE that is not only effective but also environmentally friendly and affordable. The medical supply industry heavily depends on disposable products and is increasingly under pressure to seek out sustainable alternatives.

Also, in January 2024, Inspira Technologies announced its intention to introduce a single-use disposable blood oxygenation kit, which is currently under development, for its INSPIRA ART medical device series. This kit is designed to be compatible with various life support machines, allowing the company to enter the disposable perfusion systems market. Launching the kit is part of Inspira's broader vision to replace traditional mechanical ventilators with advanced life support technologies.

Similarly, in September 2023, Medtronic plc announced that it had received CE Mark approval for its new all-in-one disposable Simplera continuous glucose monitor (CGM). This innovative device features a straightforward two-step insertion process and does not require overtape, making it user-friendly. The Simplera CGM is designed to work seamlessly with the InPen smart insulin pen, which offers real-time, personalized dosing guidance to simplify diabetes management.

Market Geographical Share

North America accounted for approximately 44.7% of the global disposable hospital supplies market share

North America region is expected to hold the largest market share over the forecast period owing to the growing incidence of infectious diseases, such as respiratory syncytial virus (RSV), which is a key factor driving the demand for disposable hospital supplies in North America. The rise in RSV cases, particularly in Canada, has led to an increased need for one-time-use products used in the management and prevention of these infections.

The surge in healthcare spending across North America is directly influencing the supply and availability of disposable hospital supplies. As hospitals in the region invest in expanding their services and upgrading facilities, there is a concurrent rise in the procurement of disposable items essential for providing quality patient care and maintaining strict infection control protocols. This increased investment in healthcare infrastructure is a significant factor driving the growth of the disposable hospital supplies market in North America.

Moreover, a major number of key player's presence, strategies such as partnerships and collaborations help to drive this market growth in this region. For instance, in May 2023, in the U.S., Indegene announced the expansion of its partnership with ConTIPI Medical Ltd, an innovator in non-surgical and disposable solutions for women with various pelvic floor dysfunctions. This collaboration aims to introduce a new device to the market, enhancing support for women suffering from pelvic organ prolapse (POP).

Similarly, in February 2021, Health Professional Resources (HPR), a U.S.-based supplier of medical goods and PPE, announced a manufacturing partnership with MAS Holdings, the largest apparel and textile manufacturer in South Asia. This partnership will allow HPR to launch a new line of high-performance PPE products for the healthcare industry, all manufactured by MAS Holdings has 53 manufacturing locations across 16 countries and is a long-time strategic partner to leading global brands like Nike and Victoria's Secret. The HPR line will include surgical gowns, isolation gowns, medical scrubs, reusable masks, and other PPE.

In addition, well-advanced healthcare infrastructure, key players agreements, and product approvals help to drive this market growth. For instance, in July 2022, Quipt Home Medical Corpa leading U.S. company in the home medical equipment sector specializing in comprehensive respiratory care, announced the signing of a contract with Cardinal Health at-Home, a division of Cardinal Health, Inc. (NYSE: CAH). Under this agreement, Quipt will sell disposable medical supplies while Cardinal Health will supply and distribute these products across the nation.

Also, in January 2024, BIOCORP, a subsidiary of Novo Nordisk based in France that specializes in the design and manufacturing of innovative medical devices, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SoloSmart. This smart medical device is designed to connect with SoloStar insulin pens produced by Sanofi.

Market Segmentation

By Product Type

Diagnostic Supplies

Dialysis Consumables

Radiology Consumables

Infusion Products

Incubation & Ventilation Supplies

Hypodermic Products

Sterilization Consumables

Non-woven Medical Supplies

Wound Care Consumables

Others

By Application

Cardiovascular

Cerebrovascular

Ophthalmology

Gynecology

Urology

Orthopedics

Others

By End-User

Hospitals & Specialty Clinics

Ambulatory Surgery Centers

Homecare Settings

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the disposable hospital supplies market include 3M, B. Braun SE, Cardinal Health, Abbott, BD, Medtronic, Nipro Europe Group Companies, Stryker, Johnson & Johnson Services, Inc., and Terumo Medical Corporation among others.

Key Developments

In March 2024, Hindustan Syringes and Medical Devices (HMD), a prominent producer of disposable and auto-disable syringes, introduced Dispojekt, a new single-use safety syringe aimed at minimizing needle stick injuries. A needle stick injury (NSI) refers to an accidental puncture of the skin caused by a hollow-bore needle that may contain blood or bodily fluids from another individual.

In February 2024, Argosy Healthcare Partners (AHP) completed a recapitalization and formed a partnership with Command Medical Products, a company specializing in the contract manufacturing of single-use medical devices. This strategic move aims to support the Command's growth and enhance its operational capabilities.

In March 2023, IceCure Medical Ltd. announced that the National Medical Products Administration (NMPA) of China has approved its IceSense3 disposable cryoprobes for commercial use. These cryoprobes are designed to work in conjunction with the IceSense3 console, which has already received NMPA approval. IceCure's ProSense System, marketed as IceSense3 in China, utilizes minimally invasive cryoablation technology to destroy tumors by freezing, providing an alternative to surgical removal.

In October 2023, Advanced Sterilization Products (ASP), announced a major expansion of its Sterilization Monitoring portfolio. The new products focused on Steam Monitoring will help Sterile Processing Departments (SPDs) in healthcare facilities ensure sterility more efficiently and with greater confidence in the results.

In February 2023, Asker Healthcare Group successfully acquired Dispo Medical B.V., a company that has been a key supplier and producer of medical consumables for hospitals and healthcare institutions in the Netherlands. This acquisition is part of Asker Healthcare's strategy to strengthen its offerings in the surgical sector and enhance its position in the European healthcare market.

Why Purchase the Report?

To visualize the global disposable hospital supplies market segmentation based on product type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the disposable hospital supplies market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global disposable hospital supplies market report would provide approximately 62 tables, 64 figures, and 184 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Number of Surgical Procedures
- 4.1.2. Restraints
  - 4.1.2.1. Rise in Waste Generated by Disposable Products
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Diagnostic Supplies *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Dialysis Consumables
6.4. Radiology Consumables
6.5. Infusion Products
6.6. Incubation & Ventilation Supplies
6.7. Hypodermic Products
6.8. Sterilization Consumables
6.9. Non-woven Medical Supplies
6.10. Wound Care Consumables
6.11. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Cardiovascular *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cerebrovascular
7.4. Ophthalmology
7.5. Gynecology
7.6. Urology
7.7. Orthopedics
7.8. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Specialty Clinics *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgery Centers
8.4. Homecare Settings
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. 3M *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. B. Braun SE
11.3. Cardinal Health
11.4. Abbott
11.5. BD
11.6. Medtronic
11.7. Nipro Europe Group Companies
11.8. Stryker
11.9. Johnson & Johnson Services, Inc.
11.10. Terumo Medical Corporation (*LIST NOT EXHAUSTIVE)